AstraZeneca earnings beat expectations as steady drug sales boost revenues

AstraZeneca plc today, on April 25, announced its earnings report for the first quarter of FY24. Total Revenue increased by 19% to $ 12,679 million, driven by an 18% increase in product sales and continued growth in Alliance Revenue from partnered medicines. Core EPS increased 13% to $2.06. The increase in Core EPS was lower […]